MedPath

Early Exposure to OMT Prevents Long LOS

Not Applicable
Completed
Conditions
Prematurity
Interventions
Other: osteopathic manipulative treatment
Other: Usual care
Registration Number
NCT01784835
Lead Sponsor
European Institute for Evidence Based Osteopathic Medicine
Brief Summary

The application of osteopathic manipulative treatment (OMT) in preterm infants has been demonstrated to be effective in reducing length of stay (LOS). The scope of the present study is to investigate the association between earlier exposure to OMT and reduction of LOS in premature infants

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
113
Inclusion Criteria
  • preterm infants born at age between 29 and 37 weeks
  • osteopathic treatment performed < 14 days after birth
  • preterms born in the same hospital
Exclusion Criteria
  • Gestational age < 29 weeks
  • Gestational age > 37 weeks
  • First OMT performed after 14 days from birth
  • genetic disorders
  • congenital disorders
  • cardiovascular abnormalities
  • proven or suspected necrotized enterocolitis with or without gastrointestinal perforation proven or suspected abdominal obstruction
  • pre/post surgery patients
  • pneumoperitoneum
  • atelectasis
  • Newborn from an HIV seropositive/drug addicted mother
  • respiratory disorders
  • transferred to/from other hospital
  • admitted for preterminal comfort care (defined as neither intubation nor cardio-respiratory resuscitation)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
OMTosteopathic manipulative treatmentpatients under usual medical care plus osteopathic treatment
controlUsual carepatients under standard medical care
Primary Outcome Measures
NameTimeMethod
Number of days of LOSparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks
Secondary Outcome Measures
NameTimeMethod
effectiveness of OMT considering different lag time between birth and the first OMTparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks

Trial Locations

Locations (1)

Macerata Hospital

🇮🇹

Macerata, Italy

© Copyright 2025. All Rights Reserved by MedPath